Wendy Brooks, a patient with extensive-stage small cell lung cancer, and her husband and care partner, Larry Brooks, sat down ...
SAVANNAH, Ga. (WSAV) — A lung cancer patient is recovering quickly after undergoing two robotic procedures. Jamie Coursey was ...
News Medical on MSN
Inflammation and immune suppression fuel aggressive SCLC behavior and spread
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only five percent. Despite this poor prognosis, SCLC is initially highly responsive ...
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%.
A team of UK researchers has developed a pioneering blood test that could enable doctors to detect and monitor lung cancer in ...
CLEVELAND — The traditional profile of a lung cancer patient—an older male smoker—no longer reflects the reality of who is being diagnosed with the disease today. Nearly 20% of new lung cancer ...
NYC Health + Hospitals/Queens was designated as a 2025 Center of Excellence in lung cancer screening by GO2 for Lung Cancer, ...
Clinical Trials Arena on MSN
Immuneering progresses MAPK inhibitor in lung and pancreatic cancer
The biotech will now take atebimetinib to mid- and late-stage trials in NSCLC and pancreatic cancer, respectively.
A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.
A multidisciplinary team integrated clinical need, cancer biology, and microfluidic bioengineering to advance ...
“Following the initial pause, the FDA has placed the trial on a partial clinical hold,” the spokesperson explained.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results